Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Capnography is defined as a monitoring tool for examining the concentration or partial pressure of CO2 in expiratory gases. Capnography is mainly used as a monitoring tool during sedation procedure and diagnosis.
The global capnography equipment market is estimated to account for US$ 823.6 Mn in terms of value by the end of 2027.
Global Capnography Equipment Market: Drivers
Increasing prevalence of asthma is expected to boost growth of the global capnography equipment market over the forecast period. For instance, according to The Global Asthma Report 2018, around 300 million people have asthma worldwide, and the number is expected to reach 100 million by 2025.
Moreover, increasing incidence of chronic obstructive pulmonary disease is also expected to propel growth of the market. For instance, according to a report by Global Initiative for Chronic Obstruction Disease’s 2018 report, chronic obstructive pulmonary disease is expected to result in 4.5 million global deaths annually by 2030.
North America held dominant position in the global capnography equipment market in 2019, accounting for 63.4% share in terms of value, followed by Europe and Asia Pacific, respectively.
Figure 1: Global Capnography Equipment Market, Regional Market Share Analysis, (%) 2020
Global Capnography Equipment Market: Restraints
Use of capnograph may lead to increased dead space and the patients need to be intubated, which is expected to hamper growth of the global capnography equipment market.
Moreover, capnography can cause rebreathing of exhaled CO2, which is also expected to hamper growth of the market.
Capnography Equipment Market Report Coverage
||Market Size in 2019:
||US$ 268.1 Mn
|Historical Data for:
||2016 to 2019
||2020 to 2027
|Forecast Period 2020 to 2027 CAGR:
||2027 Value Projection:
||US$ 823.6 Mn
- North America: U.S. and Canada
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Rest of world: GCC, Israel, Rest of Middle East
- By Type: Mainstream Capnographs, Sidestream Capnographs, Microstream Capnographs.
- By End User: Hospitals, Ambulatory, Others.
Drägerwerk AG & Co. KGaA, Masimo Corporation, Medtronic, Inc., Nihon Kohden Corporation, Nonin Medical, Inc., Philips Healthcare, Smiths Medical, and Welch Allyn, Inc.
- Increasing prevalence of asthma
|Restraints & Challenges:
- Risk associated with capnography
Global Capnography Equipment Market: Opportunities
Emergence of Covid-19 is expected to offer lucrative growth opportunities for players in the global capnography equipment market. For instance, globally, as of 4:47pm CEST, 23 September 2020, there have been 31,425,029 confirmed cases of COVID-19, including 967,164 deaths, reported to the World Health Organization.
Moreover, R&D in capnography is also expected to offer lucrative growth opportunities for players in the global capnography equipment market. For instance, in March 2019, researchers from Emergency Care Management and University of Balearic Islands, reported analysis of the feasibility and reliability of capnography use with face mask ventilation during CPR maneuvers in adults and children.
The global capnography equipment market was valued at US$ 268.1 Mn in 2020 and is forecast to reach a value of US$ 823.6 Mn by 2027 at a CAGR of 17.4% between 2020 and 2027.
Figure 2: Global Capnography Equipment Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Market Trends/Key Takeaways
High prevalence of lung cancer is expected to boost growth of the global capnography equipment market over the forecast period. For instance, according to The American Cancer Society, in 2020, the U.S. is expected to witness around 228,820 new cases of lung cancer and around 135,720 deaths due to the disease.
Major players in the global capnography equipment market are focused on conducting clinical trials to expand their product portfolio. For instance, in February 2019, Medtronic plc announced preliminary results from PRODIGY, a Microstream (TM) Capnography, multi-center study to identify people at high risk for opioid-induced respiratory depression (OIRD), a form of respiratory compromise.
Government organizations of various countries have set up some standard guidelines that mandate the use of capnography.
The American Society of Anesthesiologists (ASA) revised the standards for basic anesthetic monitoring in October 2010. The ASA stated, “During moderate or deep sedation, the adequacy of ventilation shall be evaluated by continual observation of qualitative clinical signs and monitoring for the presence of exhaled carbon dioxide unless precluded or invalidated by the nature of the patient, procedure, or equipment.” These standard guidelines for monitoring the presence of exhaled carbon dioxide, when the patient is under the effect of anesthesia, have helped the capnography market in gaining more sales in North America.
Global Capnography Equipment Market: Competitive Landscape
Major players operating in global capnography equipment market include, Drägerwerk AG & Co. KGaA, Masimo Corporation, Medtronic, Inc., Nihon Kohden Corporation, Nonin Medical, Inc., Philips Healthcare, Smiths Medical, and Welch Allyn, Inc.
Global Capnography Equipment Market: Key Developments
Major players in the global capnography equipment market are focused on product approval and launch to expand their product portfolio. For instance, in June 2019, Masimo Corporation received the U.S. FDA approval for its O3 Regional Oximetry for use on neonatal and infant patients.